Artificial Intelligence

As artificial intelligence (AI), data science, and real-world evidence become increasingly important across ophthalmology, their potential is expanding beyond image analysis alone. From identifying clinical phenotypes in heterogeneous conditions such as dry eye disease to supporting risk stratification, patient education, and more personalized follow-up care, these approaches may help clinicians interpret complex data and improve decision-making in everyday practice. We spoke with Dr Germán Mejía-Salgado (Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia) about how AI and real-world clinical data are being explored in ophthalmology, where these tools could add the most value beyond diagnostic imaging, and what will be needed for AI to become genuinely useful for ophthalmologists and their patients.

A session at the ARVO Annual Meeting 2026 explored the evolving role of AI in Age-related Macular Degeneration clinical trials, highlighting both the transformative potential of automated imaging analysis and the practical barriers that continue to limit broader implementation. Central to this discussion was the CLEAR study, an initiative led through the International Retinal Imaging Society that aims to establish a standardized validation framework for AI tools used in clinical-trial decision-making. In this Q&A, Dr Omer Trivizki (Bascom Palmer Eye Institute and Tel Aviv Medical Center) discusses how these same principles of standardization, transparency and clinically meaningful interpretation extend beyond imaging algorithms to emerging large language models. Drawing on his work at the Israeli GA Research Center and through CLEAR, he reflects on the risks of incomplete yet highly convincing AI-generated patient advice, particularly in rare inherited retinal diseases, and why clinical judgment, critical thinking and human connection must remain at the center of patient education and trial decision-making.

At the ASCRS Annual Meeting in Washington DC, digital innovation was once again high on the agenda, with the ASCRS Digital Clinical Committee showcasing how emerging technologies such as artificial intelligence are beginning to move from theory into everyday ophthalmic practice. From ambient AI scribes and smarter surgical planning to automated patient communication and workflow optimization, the message from this year’s sessions was clear: many of the tools shaping the future of practice are already available today. We caught up with Dr Eric Rosenberg following ASCRS 2026 to discuss the committee’s key takeaways, practical first steps for ophthalmologists looking to adopt AI in clinic, and how emerging technologies, including quantum computing, could influence the next decade of ophthalmic care.

Join us to read the latest news and abstract highlights from ASCRS 2026 The American Society of Cataract and Refractive Surgery Annual Meeting returned to Washington, D.C. from April 10–13, bringing together cataract, refractive, cornea and anterior segment specialists from around ...

At ASCRS 2026, artificial intelligence (AI) emerged not as a distant concept, but as a central theme shaping discussions across cataract and refractive care. This was underscored by the keynote presentation by Dr Kerry Soloman, Artificial Intelligence in Ophthalmology: Where We Are, Where We Should Go, and How to Get There Responsibly, which set the tone for a broader conversation around both the opportunities and responsibilities associated with AI adoption.

This activity provides guidance on optimizing presbyopia-correcting IOL selection and patient expectations

Designed for busy clinicians, these short, focused articles cut through theory to highlight what truly matters at the point of care including what works, what to watch for, and how to optimise outcomes in real-world settings.

2025 has brought a wave of innovation and developments that are already reshaping day-to-day clinical practice. We asked our key faculty to reflect on what they believe has been most impactful so far this year – here’s what they told us.

If you are heading to Orlando this weekend for AAO 2025, here is some good news: artificial intelligence has moved beyond the “futuristic concept” stage to become an established clinical tool. This year’s programme is full of sessions designed to demonstrate how AI can be integrated into everyday ophthalmic practice.